Chronic back pain remains a pervasive affliction, affecting approximately 16 million American adults. However, a recent study has delivered discouraging insights regarding the efficacy of common treatments.
According to research published in BMJ Evidence-Based Medicine, merely one in ten treatments demonstrated substantial relief for lower back pain. The University of New South Wales (UNSW) in Sydney, Australia, emphasized that numerous interventions offered little more than placebo-level results.
“Our analysis did not reveal compelling evidence indicating significant benefits from any of the assessed treatments,” remarked lead author Dr. Aidan Cashin, deputy director at the Centre for Pain IMPACT, Neuroscience Research Australia (NeuRA), and a senior lecturer at UNSW Sydney’s School of Health Sciences, as per Fox News.
The research synthesized findings from 301 randomized controlled trials, encompassing data on 56 non-surgical treatment approaches for adults dealing with acute or chronic low back pain or both. These interventions were compared against placebo-controlled groups.
“Evaluated treatments spanned pharmacological options, including non-steroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants, as well as non-pharmacological approaches such as exercise and massage therapy,” Cashin explained.
The study identified that exercise, steroid injections, and paracetamol (acetaminophen) offered limited efficacy for acute low back pain. Likewise, antibiotics and anesthetics were deemed ineffective for chronic cases.
NSAIDs, however, showed some promise in alleviating acute back pain. Chronic cases saw marginal benefits from therapies like exercise, spinal manipulation, taping, antidepressants, and transient receptor potential vanilloid 1 (TRPV1) agonists. Nevertheless, these improvements were described as minor.
The researchers acknowledged that insufficient sample sizes and suboptimal study quality rendered many conclusions inconclusive.
“Robust, high-quality placebo-controlled trials are necessary to clarify treatment efficacy and provide definitive guidance to patients and clinicians alike,” Cashin asserted.
Dr. Stephen Clark, a physical therapist and chief clinical officer at Confluent Health in Georgia, emphasized that the study assessed treatments in isolation.
“Excluded were studies that could not disentangle the influence of a specific intervention,” Clark, uninvolved in the research, told Fox News Digital.
He noted that pain is an intricate phenomenon influenced by numerous variables, including psychological and environmental factors.
“Pinpointing a singular cause for persistent low back pain is challenging, as underscored by the study,” Clark stated. “Stress, sleep disturbances, fatigue, fear, social environments, dietary habits, illness history, and previous pain experiences all contribute to pain perception,” according to Fox News.
Clark advocated for a comprehensive, multimodal approach to pain management, which personalizes treatments according to the patient’s unique experience.
“Evidence supports the effectiveness of physical therapy interventions combining manual therapy, active exercises, and education on pain understanding and management,” he said.
He also highlighted that treatment effectiveness can vary from person to person.
“What provides relief for one patient may not yield the same results for another,” he remarked.
While surgical procedures can be beneficial in certain cases, Clark underscored that they should be considered a last resort for non-emergency scenarios.
“Surgery may be warranted in specific situations, but it is rarely a standalone solution,” he said. “Understanding the complexities of an individual’s pain experience is essential. Conservative care often mitigates the need for invasive measures.”
